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CACCC boxes are among the critical sequences present in regulatory elements of genes expressed in
erythroid cells, as well as in selected other cell types. While an erythroid cell-specific CACCC-box-binding
protein, EKLF, has been shown to be required in vivo for proper expression of the adult b-globin gene, it is
dispensable for the regulation of several other globin and nonglobin erythroid cell-expressed genes. In the work
described here, we searched for additional CACCC-box transcription factors that might be active in murine
erythroid cells. We identified a major gel shift activity (termed BKLF), present in yolk sac and fetal liver
erythroid cells, that could be distinguished from EKLF by specific antisera. Through relaxed-stringency
hybridization, we obtained the cDNA encoding BKLF, a highly basic, novel zinc finger protein that is related
to EKLF and other Kru¨ppel-like members in its DNA-binding domain but unrelated elsewhere. BKLF, which
is widely but not ubiquitously expressed in cell lines, is highly expressed in the midbrain region of embryonic
mice and appears to correspond to the gel shift activity TEF-2, a transcriptional activator implicated in
regulation of the simian virus 40 enhancer and other CACCC-box-containing regulatory elements. Because
BKLF binds with high affinity and preferentially over Sp1 to many CACCC sequences of erythroid cell-
expressed genes, it is likely to participate in the control of many genes whose expression appears independent
of the action of EKLF.
Proteins that recognize CACCC sequences have been impli-
cated in the regulation of diverse genes in both erythroid and
nonerythroid cells. These include erythroid cell-expressed
genes, such as the b, g, and z globins (25), porphobilinogen
deaminase (11, 21), pyruvate kinase (18, 19), carbonic anhy-
drase (8), and GATA-1 (36), as well as genes expressed in
other tissues, such as those encoding the T-cell receptor (37),
tyrosine aminotransferase (2), and tryptophan oxygenase (5).
CACCC boxes are also critical components of viral regulatory
elements, such as the simian virus 40 (SV40) enhancer (39). In
addition, CACCC boxes are often found in close association
with other motifs. For example, CACCC boxes in erythroid cell
regulatory regions are frequently located ;20 to 30 bp from
GATA motifs (28). Accordingly, the erythroid transcription
factor GATA-1 physically interacts and synergistically activates
transcription with CACCC-box-binding proteins of the Kru¨p-
pel family of zinc finger proteins in transfected cells (10, 20). In
other cell types, proteins bound to CACCC motifs cooperate
with the glucocorticoid receptor (31, 34).
Recently, cDNA encoding a Kru¨ppel-related polypeptide,
designated EKLF, was characterized and demonstrated to rep-
resent a CACCC-binding protein (22). EKLF expression is
highly restricted to erythroid cells of both yolk sac and fetal
liver origins (7, 22, 27). In pursuit of its in vivo role, the EKLF
gene was disrupted in mouse embryonic stem cells and
EKLF2/2 embryos were generated (24, 27). These embryos
reveal a profound reduction in b-globin expression. Remark-
ably, other genes whose promoters contain functional CAC
CC-box elements, such as the GATA-1, porphobilinogen
deaminase, erythroid pyruvate kinase, carbonic anhydrase and
bh1 globin genes, are expressed at normal (or near-normal)
levels in EKLF2/2 embryos. These findings provide clear evi-
dence for the existence of additional CACCC-binding proteins
that are likely to control diverse target genes in erythroid cells.
In an effort to characterize these other CACCC factors, we
performed gel shift analysis of murine erythroid cell nuclear
extracts and identified a prominent activity for further study.
This activity is of particular interest in that it appears to be an
abundant CACCC-box-binding protein in erythroid cells and
binds to CACCC sequences more avidly than to GC-rich sites,
those commonly recognized by Sp1. By cDNA cloning, we have
shown that this protein, designated BKLF/TEF-2, is another
member of the Kru¨ppel family of transcription factors, distin-
guished by its basic charge (hence, BKLF). Its DNA-binding
specificity resembles that of EKLF but is distinct. We show that
BKLF binds with high affinity to numerous CACCC motifs
found in erythroid cis-regulatory elements, including those of
the b-globin, GATA-1, porphobilinogen deaminase, pyruvate
kinase, and carbonic anhydrase gene promoters and globin
locus control cores. We show that both BKLF and EKLF
proteins are expressed in murine embryonic and definitive
hematopoietic tissues; however, BKLF appears to be more
abundant. Unlike EKLF, however, BKLF is not confined to
erythroid cells but is present in a number of cell types. In the
developing mouse embryo, expression is particularly striking in
the midbrain region. Our results also suggest that BKLF cor-
responds to TEF-2/GT-IC, an activity first described in the
context of the SV40 enhancer. Taken together, our findings
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suggest that this new member of the Kru¨ppel family, BKLF/
TEF-2, is likely to fulfill critical functions in the regulation of
genes containing CACCC elements in erythroid cells, as well as
in selected other tissues.
MATERIALS AND METHODS
Cell culture, COS cell transfections, and nuclear extracts. Cell lines were
cultured in Dulbecco’s modified Eagle’s medium supplemented with glutamine,
penicillin, and streptomycin. To prepare COS cell-expressed EKLF or BKLF,
10-cm-diameter plates of COS cells were transfected with 10 mg of the expression
plasmid pSG5/EKLF (22) or pMT2/BKLF by the DEAE-dextran method (30).
At 48 h later, nuclear extracts were prepared as described previously (1). Nuclear
extracts from cell lines and murine tissues were similarly prepared.
DNA-binding assays and proteolytic clipping. Binding reactions for gel shift
assays were performed at 48C in 30 ml of 10 mM N-2-hydroxyethylpiperazine-
N9-2-ethanesulfonic acid (HEPES; pH 7.8)–50 mM potassium glutamate–5 mM
MgCl2–1 mM EDTA–1 mM dithiothreitol–5% glycerol–10 mg of bovine serum
albumin–1 mg of poly(dI-dC)–0.5 ng of 32P-labeled double-stranded oligonucle-
otide probe–5 to 10 mg of nuclear extract. After 20 min at 48C, reaction mixtures
were loaded onto a 6% nondenaturing polyacrylamide gel in 0.53 Tris-borate-
EDTA and subjected to electrophoresis at 12 V/cm at 48C for 2 h. The gels were
dried and subjected to autoradiography. The sequences of the oligonucleotides
used in gel shift experiments were as follows: b-globin, tagagCCACACCCTgg
taag and cttaccAGGGTGTGGctcta; GATA-1 distal, aggcgGCACACCCCctcccc
and ggggagGGGGTGTGCcgcct; GATA-1 proximal, actgCCCCACCCActggggc
and gccccagTGGGTGGGGcagt; PBGD distal, agctgtaggCCCCACCCTccagcag
and agctctgctggAGGGTGGGGcctac; PBGD proximal, agctgcaggGCCCACCC
Tcactgtg and agctcacagtgAGGGTGGGCcctgc; pyruvate kinase, agctagggGCA
CACCCAgcaggcag and agctctgcctgcTGGGTGTGCccct; carbonic anhydrase I,
gatcttaagtCCACACCCCaactg and gatccagttGGGGTGTGGacttaa; murine HS2,
tcgactgaACACACCCAcAGGGTGGGGagtagc and tcgagctactCCCCACCCTgT
GGGTGTGTtcag; human HS2, gatcctgggcACACACCCTaagcc and gatcggcttA
GGGTGTGTgcccag; human HS3i, gatcgccctgaCCCCACCCCaccc and gatcgggt
GGGGTGGGGtcagggc; human HS3ii, gatccatggaCTCCACCCAgcacc and gatc
ggtgcTGGGTGGAGtccatg; bh1, tagagCCCCACCCCggtaag and cttaccGGGGT
GGGGctcta; Epo receptor, tagAGCCACCCCctggtaag and cctaccagGGGGTG
GCTcta; GC-rich Sp1 site, taaatgaaGCCCGCCCCagtcgatc and gatcgactGGG
GCGGGCttcattta; g-globin, agctctaaaCTCCACCCAtggg and agctcccaTGGGT
GGAGtttag; and SV40 TEF-2 site, ccgagctagactttCCACACCCTaactgac and tcg
ggtcagttaGGGTGTGGAaagtctagc. The CACCC motifs contained in these probes
are shown in capitals.
Proteolytic clipping was performed on gel shift reactions set up as described
above. Tubes containing the nuclear extract and probe were incubated on ice for
15 min, and then various amounts of trypsin, chymotrypsin, and protease K were
added. In each series, the amounts were 0, 16, 80, and 400 ng and 2 mg. After a
further 15 min on ice, the reaction mixtures were loaded directly onto a 6%
polyacrylamide gel and subjected to electrophoresis at 12 V/cm at 48C for 2 h.
The gels were dried and subjected to autoradiography.
Expression and purification of GST fusion proteins. The region encoding
amino acids 1 to 114 of EKLF was fused in frame downstream of glutathione
S-transferase (GST) contained in the mammalian expression vector pEBB (a gift
from Bruce Mayer). To prepare protein for generating antibodies, 60 15-cm
plates of COS cells were each transfected with 30 mg of the expression vector. At
48 h after transfection, the cells were washed twice in phosphate-buffered saline
and each plate was lysed in 1 ml of 50 mM Tris z HCl (pH 7.5)–150 mM NaCl–5
mM EDTA–1 mM dithiothreitol–0.5% Nonidet P-40 at 48C. Cellular debris was
removed by centrifugation at 48C, 2 ml of glutathione-agarose beads was added,
and the solution was shaken gently for 30 min at 48C. Beads were then collected
by brief centrifugation and washed six times in cold lysis buffer. The GST-EKLF
fusion protein was then eluted by the addition of 1.2 ml of 50 mM Tris z HCl (pH
7.5)–150 mM NaCl–0.5 mM EDTA–1 mM dithiothreitol–10% glycerol contain-
ing 6 mg of reduced glutathione per ml and injected into rabbits by following
standard protocols.
To generate an antiserum against BKLF, nucleotides 1 to 848 were amplified
by PCR and cloned in frame downstream of GST in the bacterial expression
vector pGEX2TK. The GST fusion protein was expressed in bacteria and puri-
fied on glutathione beads as previously described (32).
UV cross-linking. A bromodeoxyuridine-substituted probe was generated by
incubating annealed oligonucleotides ACTAGTGGATCC and TAGAGCCAC
ACCCTGGTAAGGGATCCACTAGT in the presence of Klenow, [32P]dATP,
dCTP, and dGTP and bromodeoxyuridine, by following standard protocols (30).
This probe was then used in gel shift experiments as described above. The gel was
then exposed to UV light in a GS Genelinker UV cabinet (Bio-Rad) for 8 min.
The bands corresponding to Sp1, BKLF, and COS-expressed EKLF were iden-
tified after brief autoradiography at 48C and excised. They were then homoge-
nized, boiled in sodium dodecyl sulfate (SDS), and subjected to electrophoresis
on an SDS-polyacrylamide gel (30). The gel was then dried and subjected to
autoradiography.
Library screening. A mouse erythroleukemia (MEL) cell cDNA library con-
tained in the bacteriophage vector lgt11 was screened with a mixed probe
containing the EKLF and Sp1 zinc finger domains. These regions were amplified
from EKLF and Sp1 cDNAs by using the primer pairs GCTGAATTCACCAT
GGCGCCGCCCAAACGCAGC plus TCCGGATCCAGAGGTGACGCTTCA
TGTG and GCCAAGCTTGGCAAAAAGAAACAGCACATTTG plus GATT
TGCGGCCGCTTTGACAGATGATCGCTCCTCAT, respectively. In all, ap-
proximately 4 3 105 plaques were screened. Filters were hybridized for 16 h at
568C in 63 SSC (13 SSC is 0.15 M NaCl plus 0.015 M sodium citrate)–23
Denhardt’s solution–200 mg of sonicated salmon sperm DNA per ml–0.1% SDS,
washed twice for 30 min each in 23 SSC at 408C, and subjected to autoradiog-
raphy. The filters were subsequently washed again at high stringency (658C in
0.23 SSC) and reexposed. Twenty-two plaques which hybridized at low but not
at high stringency were selected and isolated. The inserts from these phages were
then cloned into the EcoRI site of pUC18 and sequenced.
Purification of BKLF from MEL cells.MEL cell nuclear extract was prepared
(6), dialyzed for 60 min against 1 liter of 20 mM HEPES (pH 7.8)–50 mM KCl–5
mM MgCl2–0.2 mM EDTA–20% glycerol–10 mM ZnCl2–1 mM dithiothreitol at
48C, clarified by brief centrifugation, and then passed over a monoS fast protein
liquid chromatography column (Pharmacia) equilibrated in 20 mM HEPES (pH
7.8)–50 mM NaCl–5 mM MgCl2–0.2 mM EDTA–20% glycerol–10 mM ZnCl2–1
mM dithiothreitol–0.5 mM phenylmethylsulfonyl fluoride–5 mg of pepstatin,
leupeptin, and aprotinin per ml. Bound proteins were eluted with a 60-ml gra-
dient of sodium chloride (100 mM to 1 M). Fractions (1 ml) were collected and
assayed for BKLF activity by gel shift analysis. Fractions containing BKLF
activity, free of Sp1, CAC-C, or EKLF as detected by the gel shift assay, were
pooled and dialyzed.
Schneider cell culture and transfection. Drosophila melanogaster SL2 cell
transfections were carried out as previously described (20). Cells were trans-
fected with 2 mg of the previously described reporter plasmid, which contains one
BKLF-binding site upstream of a TATA box and the bacterial chloramphenicol
acetyltransferase gene (20), and 5 mg of transactivator plasmid, either pPac alone
(17), pPac/Sp1 (26), pPac/EKLF (20), or pPac/BKLF. pPac/BKLF was con-
structed by cloning nucleotides 7 to 1179 of BKLF (i.e., a fragment containing
the entire open reading frame and a small amount of the 59 untranslated region)
between the BamHI and XhoI sites of pPac/Sp1.
In situ analysis of developing mouse embryos. Whole-mount in situ hybrid-
izations were performed essentially as described by Wilkinson (38). Nucleotides
1 to 848 of BKLF were subcloned between the BamHI and EcoRI sites of
Bluescript II KS (Stratagene) to allow for generation of antisense riboprobe by
using T3 polymerase with digoxigenin-UTP (Boehringer Mannheim). A sense
riboprobe was used as a negative control for the whole-mount analysis.
Western blotting. Cultured cells, fetal liver samples, and fetal head samples
were homogenized in SDS-polyacrylamide gel electrophoresis (PAGE) loading
dye and immediately frozen at 2808C. Equal amounts of protein were resolved
by SDS-PAGE (10% polyacrylamide), electrotransferred to nitrocellulose, and
subjected to Western blotting (immunoblotting) (30). BKLF was detected by
chemiluminescence with anti-rabbit horseradish peroxidase and a commercial kit
(Amersham) following incubation for 1 h at room temperature with a 1:1,000
dilution of the polyclonal rabbit anti-GST-BKLF antiserum. GATA-1 protein
was detected similarly with a monoclonal rat anti-mouse GATA-1 (Santa Cruz
Biotech).
Nucleotide sequence accession number. The GenBank accession number of
the BKLF sequence is U36340.
RESULTS
BKLF, a CACCC-binding activity distinguishable from EKLF.
Nuclear extract of MEL cells contains several activities which
form a complex on the b-globin CACCC sequence (14) (Fig. 1,
lane 3). The most slowly migrating complex includes Sp1 and
Sp1-related proteins (reference 14 and unpublished data). The
identity of the remaining complexes had to be established. To
determine which complex contains EKLF under our gel shift
conditions, we expressed recombinant EKLF in COS cells
(lane 1) and used an antibody to EKLF to supershift the rele-
vant complex (lane 2). With MEL cell extract, a minor complex
of similar mobility is seen (lane 3) and is also abolished by
antibody treatment (lane 4). A major complex present in MEL
cells, designated BKLF (see below), is unaffected by treat-
ment with anti-EKLF antibody. These findings suggest that the
EKLF and BKLF complexes contain distinct proteins, as judged
by immunologic criteria. This conclusion was unanticipated, as
preliminary data suggested that the BKLF complex might cor-
respond to that produced by EKLF. First, EKLF binds avidly
in vitro to the b-globin CACCC site and is required for its in
vivo expression. Likewise, the BKLF complex is formed effi-
ciently on the same site. Second, UV cross-linking experiments
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with recombinant EKLF and partially purified MEL cell BKLF
protein showed that the two proteins migrate similarly in an
SDS-polyacrylamide gel (Fig. 2). Thus, while the gel shift find-
ings presented in Fig. 1 suggest that the EKLF and BKLF
complexes contain distinct proteins, they do not exclude the
possibility that BKLF is a variant or heterodimeric form of
EKLF in which epitopes detected by antibody directed to
EKLF are either missing or masked. Finally, BKLF gel shift
activity (previously suggested to be CACD [14]) is selectively
reduced in nuclear extracts of fetal liver erythroid cells of
EKLF2/2 embryos (27; also see below).
Isolation of BKLF cDNA. To resolve the above ambiguities,
we isolated cDNA encoding the protein present in the BKLF
gel shift complex. Given that EKLF, Sp1, and the novel BKLF
activities recognize similar DNA sequences, we speculated that
the DNA-binding domain of BKLF might also be closely re-
lated to these Kru¨ppel family members. We screened a MEL
cDNA library under relaxed stringency with a mixed probe
containing sequences encompassing the zinc finger regions of
EKLF and Sp1. Twenty-two clones which hybridized to the
probe at low but not high stringency were isolated and se-
quenced. Of these, eight encoded Sp3 (five clones) and Sp4
(three clones). Three clones represented a novel transcript and
were chosen for further analysis. The largest (designated BKLF-
clone 1) contained an open reading frame of 344 amino acids,
encoding a potential polypeptide of 38.5 kDa (Fig. 3a).
Inspection of its deduced polypeptide sequence reveals that
BKLF is a member of the Kru¨ppel family and most highly
related in its zinc finger region to BTEB2 (33) (Fig. 3b). In this
region, BKLF is also highly related to EKLF, Sp1, and BTEB1
(16). Outside the finger region, BKLF is unrelated to these
proteins; however, like EKLF, it is proline rich. Although its
calculated molecular weight is similar to that of EKLF, the
predicted BKLF polypeptide is considerably more basic, with a
calculated isoelectric point of 10.2 compared with 7.0 for
EKLF. This finding presumably accounts for the slower mo-
bility of the BKLF complex in native gels yet the equivalent
migration of EKLF and BKLF polypeptides in the presence of
SDS (Fig. 2).
Proteolytic clipping establishes that BKLF-clone 1 encodes
BKLF. Nuclear extract of COS cells expressing recombinant
protein encoded by the BKLF clone was used in gel shift as-
says. A complex was generated on the b-globin probe that co-
migrates with partially purified BKLF of MEL cells and with
BKLF present in MEL cell nuclear extract (Fig. 4 and 5a). To
verify that the protein encoded by BKLF-clone 1 is BKLF,
proteolytic clipping experiments were performed. Samples of
nuclear extract of COS cells expressing the cDNA and partially
purified MEL cell BKLF were digested with increasing amounts
of chymotrypsin, trypsin, or protease K immediately prior to
gel retardation analysis. The profiles generated by digestion of
partially purified MEL BKLF and the expressed candidate
clone were indistinguishable (Fig. 4). The comigration of COS-
expressed BKLF-clone 1 and BKLF from MEL cells (Fig. 4
and 5a and unpublished results) strongly suggests that the
BKLF clone-1 cDNA represents a full-length clone of BKLF.
The authenticity of this clone is further supported by antibody-
supershifting experiments described below.
BKLF is the major CACCC factor expressed in yolk sac and
fetal liver of the developing mouse. To authenticate the cDNA
and analyze the expression pattern of BKLF protein in various
cell types, we raised antibody directed to the amino-terminal
268 amino acids of the predicted polypeptide, a region which
shows no significant homology to other zinc finger proteins. As
shown in Fig. 5a, the antibody supershifted the recombinant
BKLF complex in COS cells (lanes 1 and 2), as well as the
BKLF complex in MEL cells (lanes 7 and 8). These findings
confirm proteolytic clipping experiments and demonstrate that
the BKLF protein is solely responsible for the BKLF gel shift
observed in MEL cells.
FIG. 1. BKLF is a major CACCC-binding activity in MEL cells. A gel shift
assay was performed with a double-stranded oligonucleotide probe containing
the mouse b-globin CACCC site and nuclear extracts of COS cells expressing
recombinant EKLF (lanes 1 and 2) and MEL cells (lanes 3 and 4). Protein-DNA
complexes containing Sp1, BKLF, and EKLF are indicated. Preimmune serum or
anti-EKLF antibody was added to the samples in lanes 1 and 3 and lanes 2 and
4, respectively.
FIG. 2. BKLF and EKLF migrate similarly under denaturing conditions. Sp1,
BKLF, and EKLF protein complexes were isolated and exposed to UV light to
cross-link the protein and probe. Samples were then electrophoresed through an
SDS-polyacrylamide gel and exposed to film. The migration reflects the total
molecular mass of the cross-linked complex (protein plus probe).
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We also assessed BKLF in nuclear extracts of purified yolk
sac and fetal liver erythroid cells (lanes 3 to 6). BKLF is pres-
ent at similar abundances in yolk sac and fetal liver erythroid
cells (lanes 3 to 6). It should be noted that BKLF antibody
fails to inhibit Sp1- or EKLF-containing complexes. Moreover,
EKLF antibody specifically removes the EKLF gel shift in the
same erythroid-cell extracts (Fig. 5b). These results indicate
that BKLF is the major component of the gel shift band des-
ignated BKLF in MEL cells and also in developing murine
erythroid tissues (yolk sac and fetal liver).
BKLF transcripts are highly expressed in the developing
midbrain region. In cell lines, BKLF is widely but not ubiqui-
tously expressed (see below). To gain further insights, whole-
mount in situ hybridization analysis of BKLF expression was
performed with murine embryos at 7.5 to 10.5 days postcoitum
(p.c.). Strong staining was initially detected at 8.5 days p.c. as
a broad band in the midbrain and anterior hindbrain (Fig. 6A)
and also in the ventral forebrain (Fig. 6B). At 9 days pc, diffuse
staining was detected in the ventral anterior half of the embryo
with restricted signals at a circle at the midbrain-hindbrain
junction as well as the ventral midbrain, diencephalon, and
forebrain (Fig. 6C). At 10.5 days p.c., expression was more
widespread (Fig. 6D), with less intense staining also detected
in the developing limb buds. Although BKLF RNA (data not
shown) and protein are present in the yolk sac, transcripts are
not readily detected by in situ analysis, presumably because of
the lower sensitivity of the method.
BKLF corresponds to TEF-2/GT-IC. The BKLF gel shift
resembles that previously termed TEF-2 (or GT-IC) (39).
TEF-2 was originally described as an activity that binds to the
FIG. 3. Deduced primary structure of BKLF. (a) The nucleotide and amino acid sequences of BKLF-clone 1. The first potential initiator codon (ATG) begins at
nucleotide 45. Another ATG (at nucleotide 84) lies in a more favorable Kozak consensus. No additional potential initiator codons or in-frame stop codons were
identified in the sequences of other clones extending further to the 59 direction. Additional 39 untranslated region sequences present in clone 1 are not shown. The open
reading frame encodes 344 amino acids, including 49 proline residues. (b) Comparison of the zinc finger DNA-binding domains of BKLF, BTEB2, EKLF, BTEB, and
Sp1. Amino acids believed responsible for determining the binding specificity of Kru¨ppel-related fingers are denoted by asterisks above the sequences.
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GT-I motif of the SV40 enhancer and the CACCC box of the
b-globin promoter. TEF-2 activity is observed in HeLa cells
and F9 cells but is undetectable in CV-1, BJA-B, MPC11,
MOLT-4, or 70Z/3 cells. Hence, TEF-2 was considered to be
cell specific or developmentally regulated. Subsequently, other
investigators have observed a CACCC-binding activity comi-
grating with TEF-2 in various cell types and have come to
regard TEF-2 as a single, ubiquitous protein (18).
To determine the relationship between BKLF and TEF-2/
GT-IC, we used a probe encompassing the TEF-2-binding site
in the SV40 enhancer and performed gel shift experiments
comparing HeLa and MEL cell extracts. As shown in Fig. 7,
FIG. 4. Proteolytic clipping of recombinant BKLF expressed in transfected COS cells and partially purified MEL BKLF. A gel shift experiment was carried out as
in Fig. 1, except that the samples were first exposed to a brief treatment by the indicated proteases. The samples were electrophoresed in parallel. For this figure, a
longer autoradiographic exposure of the MEL samples has been used to facilitate comparisons.
FIG. 5. BKLF and EKLF gel shift complexes in yolk sac and fetal liver samples. (a) BKLF is a major CACCC-box-binding activity in murine erythroid tissues. Gel
shift assays were performed with the b-globin CACCC-site probe and nuclear extracts from the indicated sources. The complexes are designated as in Fig. 1. Preimmune
serum or anti-BKLF antibody was added to lanes 1, 3, 5, and 7 and lanes 2, 4, 6, and 8, respectively. In lanes 1 and 2, 2 mg (rather than 10 mg) of nuclear extract was
used; therefore, the endogenous Sp1 complex in COS cells is barely visible. (b) Detection of the EKLF complex in murine erythroid tissues. The experiment was
performed as in panel a. Preimmune serum or anti-EKLF antibody was added to lanes 1, 3, 5, and 7 and lanes 2, 4, 6, and 8, respectively. The EKLF complexes in the
fetal liver and MEL cell samples (lanes 5 and 7) were barely detectable in this experiment but were confirmed in other preparations.
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the TEF-2 gel shift is formed on the SV40 probe and is inhib-
ited by BKLF antibody. This result suggests that BKLF gen-
erates the TEF-2 gel shift observed in HeLa cells.
In certain cell lines, non-BKLF/TEF-2 proteins generate a
TEF-2-like gel shift. A gel shift activity resembling BKLF/
TEF-2 has been observed in a variety of cell lines. Northern
blotting shows that BKLF transcripts are expressed widely in
the adult (Fig. 8a). On this basis, it might be presumed that
TEF-2 is a ubiquitous DNA-binding protein. To determine if
this is the case, we performed additional supershift experi-
ments. As shown in Fig. 8b, all cell lines tested exhibited a
BKLF/TEF-2-like gel shift activity but BKLF was a major com-
ponent of this complex only in MEL, K562, HeLa, and NIH
3T3 cells. In COS, Jurkat, mouse embryonic stem (ES), and
293 cells, BKLF constituted a minor proportion of or was
undetectable in the gel shift complex. Thus, BKLF/TEF-2 is
not strictly ubiquitous in its distribution.
BKLF is selectively reduced but present in EKLF2/2 fetal
liver erythroid cells. We previously reported that a major gel
shift activity (then referred to as CACD [14]) was markedly
FIG. 6. Whole-mount in situ hybridization analysis of BKLF. Embryos are shown at 8.5 days p.c. (4 to 5 somites) (A), 8.5 days p.c. (7 to 8 somites) (B), 9 days p.c.
(12 to 13 somites) (C), and 10.5 days p.c. (D). BKLF expression was first detected as a broad band in the midbrain and anterior hindbrain (arrow in panel A). Later,
specific expression also extended ventrally in the central nervous system, with strong staining in the ventral forebrain (open arrow) as well as the midbrain and anterior
hindbrain (solid arrow). At 9 days p.c. prominent, diffuse expression was evident in the ventral anterior half of the embryo, but in the midbrain, staining was restricted
to a circle at the midbrain-hindbrain junction (arrow in panel C). At 10.5 days p.c., expression was more widespread but strong staining was still evident in the central
nervous system, particularly at the midbrain-hindbrain junction (arrow), as well as the ventral midbrain, diencephalon, and forebrain. Less intense staining was also
detected in the developing limb buds (arrowhead in panel D). ys, yolk sac.
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reduced in EKLF2/2 fetal liver erythrocytes compared with
the activity in EKLF1/2 erythroid cells and MEL cells (27).
Although the simplest interpretation might be that this reflects
the level of EKLF itself, our current data distinguishing BKLF
and EKLF show this not to be the case. As shown in Fig. 9a,
the BKLF gel shift is reduced but not absent in EKLF2/2
erythroid cells, as would be anticipated if this complex con-
tained EKLF. In addition, antibody supershift experiments
establish that the complex contains BKLF. The reduced level
of BKLF gel shift activity is due to less protein (approximately
5- to 10-fold), as shown by Western blot analysis of fresh fetal
liver samples (Fig. 9b). As a control for the erythroid cell
contribution to these fetal liver samples, the Western blot was
reprobed with GATA-1 antiserum, which demonstrated equiv-
alent loading of extracts. In contrast to these findings, BKLF
protein was equally abundant in head regions of EKLF2/2 and
EKLF1/2 embryos (Fig. 9b). Also, as shown in Fig. 9b, BKLF
protein is more abundant in mature than immature MEL cells.
Therefore, BKLF protein is selectively reduced but not ab-
sent in erythroid cells lacking EKLF. This effect is not at the
transcriptional level, because BKLF transcripts appear to be
equally abundant in EKLF2/2 and control samples (not shown).
These findings are discussed below.
BKLF functions as a transcriptional activator. We also in-
vestigated whether BKLF, like its related proteins EKLF and
Sp1, can serve as a transcriptional activator. Perhaps because
of the presence of endogenous CACCC-box-binding proteins,
it has proved challenging to devise suitable transactivation
assays for these proteins in mammalian cells. In this instance,
transactivation experiments with Drosophila cells, which do not
contain endogenous Sp1, have been helpful. A chloramphen-
icol acetyltransferase reporter gene, under the control of the
b-globin TATA box and a single BKLF-binding site, was trans-
fected into Drosophila Schneider cells in the absence or pres-
ence of an expression vector encoding BKLF. As shown for a
representative experiment in Fig. 10, BKLF activated tran-
scription ;5- to 10-fold. Under the same conditions, EKLF
and Sp1 also activated transcription from the reporter plasmid,
albeit at somewhat higher levels. We conclude that BKLF is
able to function as a transcriptional activator.
BKLF and EKLF both bind strongly to the b-globin CACCC
motif. Although all CACCC-box-binding proteins so far de-
scribed recognize both CACCC and CGCCC sequences, they
display clear preferences. EKLF, for instance, binds more
readily to the b-globin than the g-globin CACCC box (CCA
CAC CCT versus CTC CAC CCA) and prefers CACCC to
CG-rich sequences (references 7 and 9 and unpublished re-
sults). Conversely, Sp1 binds preferentially to GCC CGC CCC
compared with the b-globin CACCC box (references 14 and 39
and unpublished results). We performed competition analysis
to determine the preference of BKLF. MEL cell nuclear ex-
FIG. 7. BKLF corresponds to the HeLa gel shift activity designated TEF-2
(or GT-IC). In this gel shift experiment, a double-stranded oligonucleotide probe
containing the SV40 enhancer CACCC-box sequences was used. Preimmune
serum or anti-BKLF antibody was added to lanes 1 and 3 and lanes 2 and 4,
respectively.
FIG. 8. BKLF/TEF-2 is widely expressed. (a) Northern blot analysis of adult tissues. (b) Assay of BKLF protein in various cell lines. The b-globin CACCC-box
sequence was used as a probe. Preimmune (lanes 2) or anti-BKLF (lanes 1) antibody (Ab) was added to each sample.
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tract was used so that BKLF binding could be directly com-
pared with the binding of Sp1 family proteins. As shown in Fig.
11a, the b-globin CACCC box competes most effectively for
the binding of BKLF whereas the g-globin and CG-rich se-
quences compete more effectively for Sp1-like binding. With
respect to these binding properties, BKLF appears to resemble
EKLF more than it resembles the Sp1 family of proteins, a
result which is consistent with its high homology to EKLF in its
zinc finger region.
BKLF binds avidly to CACCC motifs found in many ery-
throid cell genes. A combination of functional assays and in
vivo and in vitro analyses have identified CACCC boxes in the
cis-regulatory regions of numerous erythroid cell genes. As a
first step to considering which of these might be targets of
BKLF, we carried out gel shift experiments to determine which
of these bind strongly to BKLF and therefore might be candi-
date target genes in vivo. Initially, BKLF binding was assessed
directly by using each site as a probe (data not shown), and
then the ability of each site to compete for the binding of
BKLF to the b-globin CACCC box was monitored (Fig. 11b).
In all, 13 different CACCC sites were found to bind BKLF
(summarized in Table 1). Of these, the CACCC sequences
present in the b- and bh1-globin, rat erythroid pyruvate kinase,
erythroid carbonic anhydrase I promoters, the proximal site in
the GATA-1 promoter, the distal site in the PBGD promoter,
and two sites in the human locus control region (one in HS2
and one in HS3) bound strongly.
DISCUSSION
A prerequisite for understanding the combinatorial mecha-
nisms that govern patterns of gene expression is characteriza-
tion of the relevant component proteins. CACCC-box-binding
proteins have been implicated in the regulation of numerous
erythroid cell genes (4, 12, 15, 18, 19). Their identification
and study have been hampered by the multiplicity of factors
that recognize a single motif (14, 22). The observation that
EKLF2/2 mice have impaired b-globin production but appear
to express other genes normally suggests that additional CAC
CC-binding proteins play a role in transcriptional control in
erythroid cells and/or compensate for the loss of EKLF. Here,
we have described the cloning of a cDNA encoding a novel
CACCC-box-binding protein (BKLF), which appears to be the
predominant CACCC factor present in nuclear extracts of
erythroid cells. We have shown that BKLF is a member of the
Kru¨ppel family of transcription factors and is highly related in
its DNA-binding domain to EKLF (and its relatives BTEB2
and BTEB1) but unrelated in other domains.
Our data suggest that BKLF is equivalent to the previously
described activity TEF-2/GT-IC. We also show that BKLF is a
FIG. 9. Reduced BKLF protein in EKLF2/2 erythroid cells. (a) Gel shift assay of nuclear extracts of MEL cells or fetal liver-derived erythroid cells from embryos
sacrificed at embryonic day 15. The indicated genotype was determined as described previously (27) and is indicated above the lanes. The b-globin CACCC site was
used as the probe. Addition of antibody is indicated by1. (b) Western blot of cultured cells and primary fetal tissues with anti-BKLF and anti-GATA-1 antisera. Nuclear
extracts (1 mg) from untreated or dimethyl sulfoxide-induced MEL cells (MEL-In), whole-cell extracts (3 mg) of tissues and other cultured cells, or extract (30 ng) of
COS cells transiently transfected with pMT2-BKLF were loaded as indicated. MW, molecular weight (in thousands).
FIG. 10. BKLF functions as a transactivator in Drosophila cells. Expression
plasmids of vector alone, EKLF, Sp1, or BKLF were cotransfected with a
CACCC-reporter construct. The chloramphenicol acetyltransferase (CAT) ac-
tivity is represented as the percent conversion achieved after 60 min at 378C.
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major CACCC-binding species in murine yolk sac and fetal
liver erythroid cell nuclear extracts. As detected by gel shift
assay, it appears considerably more abundant than EKLF in
these tissues. Others have described multiple CACCC-binding
activities in MEL cell extracts (14). Initially, we presumed that
the complex designated BKLF corresponded to CACD of
Hartzog andMyers by comparison of our gel shift patterns with
their published findings (14, 27). Unless BKLF and EKLF
complexes were not resolved under their gel shift conditions,
this conclusion is untenable, since purified protein thought to
represent CACD reacts with EKLF antibody (2a). Because of
the difficulties inherent in comparing gel shift patterns ob-
tained with different cell lines and in different laboratories, we
cannot easily relate our findings to the gel shift complexes
previously designated CACC and CACD (14). It seems most
prudent to discuss only those complexes for which molecular
reagents (cDNA and antibodies) are characterized.
As with other sets of transcription factors that recognize
similar or identical sequences, it is difficult to ascribe specific
functions to particular members of the CACCC-binding family
other than EKLF. In the instance of EKLF a specific role in
b-globin gene transcription is suggested by in vitro transacti-
vation studies (3) and more conclusively established by the
EKLF2/2 phenotype (24, 27). The original studies of the SV40
enhancer revealed a correlation between the binding of TEF-
2/GT-IC, presumed here to be BKLF, and enhancer activity
(23), consistent with our observation that BKLF can function
as a transcriptional activator. There remains the outstanding
question of the nature of the cellular genes regulated by BKLF
in vivo. Given the finding that the promoters of diverse genes
depend on CACCC sites for their activity, many will be candi-
date targets for BKLF. In surveying binding sites, we have
identified a subset of sites that are preferred by BKLF. Some
are of particular interest. The favorable CACCC site in the
bh1-globin promoter suggests that BKLF, rather than EKLF,
may participate in its regulation in vivo, a possibility consistent
with its normal expression in EKLF2/2 embryos. A high-affin-
FIG. 11. Binding-site preferences of BKLF. (a) BKLF prefers the b-globin
CACCC sequence. Gel shift assays included MEL cell nuclear extract, the b-glo-
bin CACCC sequence as the probe, and increasing concentrations (0, 5, 15, and
45 ng) of each indicated competitor sequence. (b) Competition analysis of se-
lected CACC sequences. Gel shift assays included MEL cell nuclear extract, the
b-globin CACCC sequence as the probe, and increasing concentrations (0, 2.5,
7.5, and 22.5 ng) of each indicated competitor sequence. E-PK, erythrocyte
pyruvate kinase; CA, carbonic anhydrase. Sequences of the sites are provided in
Table 1. The mouse HS2 sequence contains two neighboring CACCC sequences.
TABLE 1. CACCC sites that bind BKLFa
Site Sequence
Strong sites
b-Globin promoter.......................................agagCCACACCCTggtaa
bh1-Globin ....................................................agagCCCCACCCCggtaa
Pyruvate kinase.............................................agggGCACACCCAgcagg
GATA-1 (proximal site)..............................actgCCCCACCCActggg
Human HS3 (site i) .....................................ctgaCCCCACCCCaccc
Carbonic anhydrase I...................................aagtCCACACCCCaactg
Human HS2 ..................................................gggcACACACCCTaagcc
PBGD (distal site) .......................................taggCCCCACCCTccagc
Weaker sites
GATA-1 (distal site)....................................ggcgGCACACCCCctccc
Human HS3 (site ii) ....................................tggaCTCCACCCAgcacc
PBGD (proximal site) .................................caggGCCCACCCTcactg
Murine HS2 (site 1).....................................ctgaACACACCCAcaggg
Murine HS2 (site 2).....................................tactCCCCACCCTgtggg
Erythropoietin receptor............................... tagAGCCACCCCctggt
a Binding sites were assigned as strong or weak on visual inspection of the
competition data shown in Fig. 11b and the relative binding of individual probes
to BKLF in gel shift assays (not shown).
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ity site in the promoter of the GATA-1 gene suggests a poten-
tial role for BKLF in activating or maintaining expression of
this central erythroid cell transcription factor. Moreover, the
presence of high-affinity sites in evolutionarily conserved se-
quences of the b-LCR HS2 and HS3 cores (13, 29, 35) raises
the possibility that BKLF functions at these upstream, domi-
nant regulatory elements. Nonetheless, it is apparent that
other proteins, such as Sp1 and other, as yet uncharacterized
activities (e.g., CACC [14]), may be the true effector proteins
at some of these sites in vivo. Ongoing targeted disruption of
the BKLF gene in ES cells should assist in pinpointing relevant
in vivo targets, particularly in concert with creation of double-
knockout BKLF2/2/EKLF2/2 embryos.
The decreased level of BKLF protein but not mRNA in
EKLF2/2 erythroid tissue (Fig. 9) is an unexpected secondary
consequence of EKLF loss. We suspect that this arises from
failure of complete maturation of EKLF2/2 erythroid cells.
Consistent with this interpretation is the accumulation of
BKLF protein during MEL cell differentiation (Fig. 9b). These
findings underscore complex cellular effects that confound
analysis of knockouts that ultimately interfere with production
of end-stage, differentiated cells.
Although we characterized BKLF in the context of CACCC
factors in erythroid cells, it seems probable that it functions in
a variety of tissues. Northern blotting shows that BKLF tran-
scripts are expressed widely in the adult (Fig. 8a). In the de-
veloping mouse embryo, high-level expression is more re-
stricted, principally to the midbrain and anterior hindbrain
region. Thus, a role for BKLF in central nervous system de-
velopment will have to be considered. Our finding that a
BKLF/TEF-2-like gel shift complex in some cells does not
contain BKLF raises an additional note of caution in assigning
CACCC-box factors from gel shift experiments without confir-
matory antibody inhibition studies.
Like GATA motifs and NF-E2 sites, CACCC boxes have
long been recognized as critical sequences in the regulatory
regions of erythroid cell-expressed genes (25). With the clon-
ing of cDNA for EKLF, the first unequivocal regulator of
erythroid CACCC-dependent genes emerged (22). As shown
by the phenotype of EKLF2/2 embryos, erythroid cells have a
circumscribed requirement for EKLF (24, 27). The findings
reported here suggest that BKLF/TEF-2, on the other hand, is
a candidate to fulfill broader functions in this lineage and
selected other cell types.
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